Skip to content

Albuterol for acute anticholinesterase pesticides poisoning

Albuterol as an Adjuvant Therapy in Acute Anticholinesterase Pesticides Poisoning: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210331050797N1
Enrollment
80
Registered
2021-05-30
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute anticholinestrase pesticide poisoning. Poisoning by, adverse effect of and underdosing of anticholinesterase agents

Interventions

Intervention 1: Intervention group (Group I): 40 patients will be enrolled. They will receive albuterol (The albuterol used in this trial is Farcolin Respirator Solution made by PHARCO Pharmaceuticals

Sponsors

Tanta Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients (male or female, aged 12 years or older) with moderate or severe acute anticholinesterase poisoning

Exclusion criteria

Exclusion criteria: Age less than 12 years old Pregnancy Lactation Ingestion or exposure to other substances in addition to the anticholinesterase agent Presence of other major medical conditions (e.g. respiratory or cardiovascular diseases, renal or hepatic failure) Delay more than 12 hours since exposure to the anticholinesterase agent (late presenters) Asymptomatic or mild poisoning with anticholinesterase agents Receiving unreported treatment before admission to our center

Design outcomes

Primary

MeasureTime frame
Oxygen saturation. Timepoint: From the start of intervention up to 60 minutes after intervention. Method of measurement: Pulse oximetry and arterial blood gas measurement.

Secondary

MeasureTime frame
Mortality. Timepoint: From admission till the discharge of patient. Method of measurement: Clinical evaluation.;Need for mechanical ventilation. Timepoint: From admission till the discharge of patient. Method of measurement: Clinical evaluation.;Length of hospital stay. Timepoint: From admission till the discharge of patient. Method of measurement: Total number of hours passed from admission till discharge.;The time needed for atropinization and the dose of atropine required for full atropinization . Timepoint: From the time of atropine administration until full atropinization occurs. Method of measurement: Clinical evaluation.

Countries

Egypt

Contacts

Public ContactDr. Samar youssef

Tanta Faculty of Medicine

samar.zein@med.tanta.edu.eg+20 40 3337544

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026